Sionna Therapeutics, Inc. · NASDAQ:SION
Viking Global Investors LP reported a 7.10% stake in Sionna Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Viking Global Investors LP reported a 7.10% stake in Sionna Therapeutics, Inc., 3,195,181 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 7.10%
- Shares
- 3,195,181
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 7.10% | 3,195,181 |
| Viking Global Opportunities Parent GP LLC | 7.10% | 3,195,181 |
| Viking Global Opportunities GP LLC | 4.50% | 2,039,801 |
| Viking Global Opportunities Portfolio GP LLC | 4.50% | 2,039,801 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 4.50% | 2,039,801 |
| Viking Global Opportunities Drawdown GP LLC | 2.60% | 1,155,380 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 2.60% | 1,155,380 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 2.60% | 1,155,380 |
| HALVORSEN OLE ANDREAS | 7.10% | 3,195,181 |
| Shabet Rose Sharon | 7.10% | 3,195,181 |
Source
Related
- Sionna Therapeutics, Inc.
- Viking Global Investors LP
- Sionna Therapeutics, Inc. shareholders
- Schedule 13G · Viking Global Investors LP · Feb 14, 2025
- Form 4 · Ra Capital Management, L.P. · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 21, 2026
- Form 4 · Ridloff Elena · Sep 18, 2026
- Form 4 · McKee Charlotte · Sep 18, 2026
- Form 4 · Fitzpatrick Jennifer · Sep 18, 2026